EMCC European Monitoring Centre on Change

Salutas Pharma

Company/Organisation:
Salutas Pharma

Geographic Location

Country: Germany
Region: Bördekreis; Magdeburg; Sachsen-Anhalt
Location of affected unit(s): Barleben

Company

Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21.10 - Manufacture of basic pharmaceutical products
Number Employed: 1172
Group: Sandoz

Employment Effects

Announcement Date: 13-10-2017
Planned Job Reductions min: 150
Planned Job Reductions max: 150
Type of Restructuring: Internal restructuring
Employment Effect Start: 01-01-2018
Foreseen End Date: 31-03-2018
Other Job Reduction Measures: 150

Additional Information

On 13 October 2017, the German pharmaceutical company Salutas Pharma GmbH confirmed the loss of 150 jobs at its site in Barleben due to internal restructuring. The job reduction process will take place in the first quarter of 2018. Management argues that cuts are inevitable due to a decline in sales from 10 billion pills per year to 8 billion pills per year.

Works council and management have started negotiations regarding a social plan.

As of October 2017, Salutas Pharma GmbH has 1,172 employees in Barleben.